甲状腺相关眼病

  • 网络Thyroid associated ophthalmopathy;Tao;thyroid associated ophthalmopathy,TAO;Thyroid Associated Ophthalmopathy TAO
甲状腺相关眼病甲状腺相关眼病
  1. 因此,对甲状腺相关眼病患者活动度评定的准确性和客观性关系到患者的治疗方案、疗效及预后,眼眶生长抑素受体显像在判断其活动度及评价治疗效果方面有重要的意义。

    The veracity and objectivity of TAO activity degree assessment determine patient 's treatment project , curative effect and prognosis . There is important significance of jugging activity and evaluating curative effect by somatostatin receptor scintigraphy in TAO .

  2. MRI在甲状腺相关眼病严重度分级的应用

    Application of MRI on Severity Grading in Thyroid Associated Ophthalmopathy

  3. MRI对甲状腺相关眼病球后放射治疗疗效的预测

    MRI predicting the outcome of orbital radiotherapy for thyroid associated ophthalmopathy

  4. 甲状腺相关眼病Ⅰ型患者CT与内分泌变化的相关研究

    Correlation of orbital computed tomography and incretion in patients with thyroid associated ophthalmopathy - ⅰ

  5. 方法将22例(32只眼)甲状腺相关眼病上睑退缩患者,随机分为A、B两组。

    Methods Twenty-two patients ( 32 eyes ) with inactive thyroid associated-ophthalmopathy were divided into 2 groups ( 11 for each group ) randomly .

  6. 结论:甲状腺相关眼病Ⅰ型患者CT表现特点与其内分泌变化关系密切,可作为临床随访的有效指标之一。

    Conclusion : The manifestation of orbital CT may be a good index in the following survey of thyroid associated ophthalmopathy - ⅰ .

  7. 目的探讨手术治疗甲状腺相关眼病(Thyroidassociatedophthalmopathy,TAO)致限制性斜视的适应证、方法和效果。

    Objective To identify the indication , method and therapeutic results of extraocular muscle surgery for thyroid associated ophthalmopathy ( TAO ) .

  8. 甲状腺相关眼病眼眶前脂肪细胞分化与HLA-DR相关因素的研究

    The Study of Related Factors on Differentiation and HLA-DR in Thyroid-Associated Ophthalmopathy Orbital Preadipocytes

  9. 目的探讨静止期甲状腺相关眼病(TAO)患者眼外肌病变的手术治疗时机、方法和效果。

    Objective To investigate the surgical timing of extraocular muscle surgery and its effect for stationary thyroid associated ophthalmopathy ( TAO ) .

  10. 目的:研究甲状腺相关眼病(TAO)与正常人眼眶前脂肪细胞表面抗原的表达。

    Objective To study the cell surface antigen expression of orbital preadipocytes between patients with thyroid-associated ophthalmopathy ( TAO ) and healthy adults .

  11. 甲状腺相关眼病(TAO)是目前医学上难以治愈的一种疾病,它有着慢性自身免疫反应的过程,病变累及眶内球后间隙。在病因方面与自身免疫性甲状腺疾病有着密切联系。

    Thyroid Associated-ophthalmopathy ( TAO ) is a medically incurable , chronic autoimmune process that affects the retroorbital space and appears to have strong etiological links with autoimmune thyroid disease .

  12. 方法:对46例甲状腺相关眼病患者及50例健康成人对照组行眼眶冠状面和横轴面CT扫描,测量各眼外肌径线及CT值,并将患者组CT表现与其内分泌变化作相关性分析。

    Methods : 92 orbits of 46 patients with thyroid associated ophthalmopathy were evaluated by CT in respect to the density and the size of extraocular muscles , and 100 normal orbits of 50 healthy persons were evaluated with the same indices for comparison .

  13. 目的评价图形视诱发电位(P-VEP)在甲状腺相关眼病视神经病变(DON)中的诊断价值及其影响因素。

    Objective To evaluate the function of the pattern visual evoked potential ( P-VEP ) in the diagnosis of dysthyroid optic neuropathy .

  14. CD40-CD40L与甲状腺相关眼病

    CD40 and CD40 ligand in thyroid associated ophthalmopathy

  15. 方法对甲状腺相关眼病患者34例56眼,采用曲安奈德10mg联合地塞米松5mg患眼球周注射,2周1次,2个月为一疗程。

    Methods Thirty-four cases ( 56 eyes ) of Graves ophthalmopathy were treated with retrobulbar injection triamcinolone acetomide ( 10mg ) and dexamethasone ( 5mg ) once every two weeks and two months in one course .

  16. 结果:患者组与对照组眼外肌径线及CT值有显著性差异,Ⅰ型甲状腺相关眼病患者眼外肌最大径线值与其T3、T4呈正相关,与TSH之间呈负相关。

    Results : There was significant difference in the density and the size of extraocular muscles between the patients and the healthy adults . The maximal size of extraocular muscles was in positive correlation with T_3 , T_4 in TAO - ⅰ, and in negative correlation with TSH .

  17. 本文就CD40-CD40L的结构和分布、对免疫反应的调节及其在甲状腺相关眼病发病中的作用作一综述。

    We reviewed the structure and expression of CD40 and its ligand , focusing on the function of CD40-CD40L in regulating immune responses of thyroid associated ophthalmopathy .

  18. 糖皮质激素冲击疗法治疗重症甲状腺相关眼病26例

    High-dose corticosteroid therapy for 26 patients with severe thyroid associated ophthalmopathy

  19. 两种术式矫正甲状腺相关眼病上睑退缩的临床研究

    Correction of upper eyelid retraction in patients with thyroid - associated-ophthalmopathy

  20. 重组人抵抗素对甲状腺相关眼病患者眼眶前脂肪细胞增殖的影响

    Recombinant human resistin on proliferation of orbital pre-adipocytes in thyroid-associated ophthalmopathy patients

  21. 单克隆抗体检测甲状腺相关眼病T细胞亚群

    T Lymphocyte subsets in Thyroid Associated Ophthalmopathy by using monoclonal antibodies technique

  22. 甲状腺相关眼病性角膜上皮缺损的治疗新途径

    A new method to treat corneal epithelial defect of thyroid associated ophthalmopathy

  23. 眼眶脂肪与甲状腺相关眼病

    Study on the orbital fat related to thyroid associated ophthalmopathy

  24. 甲状腺相关眼病生活质量的初步研究

    The Preliminary Study of the Quality of Life in Thyroid Associated Ophthalmopathy

  25. 大剂量泼尼松与环磷酰胺-长春新碱-泼尼松方案治疗甲状腺相关眼病的临床疗效比较

    Treatment of thyroid-associated ophthalmopathy : comparative study between prednisone and COP therapy

  26. 静止期甲状腺相关眼病患者眼外肌病变的手术治疗

    Extraocular muscle surgery in patients with stationary thyroid-associated ophthalmopathy

  27. 固视野检查对甲状腺相关眼病眼外肌功能的测量分析

    The Clinic Value of Fixed Visual Field Examination in Patients with Thyroid-associated Ophthalmopathy

  28. 甲状腺相关眼病381例临床分析

    Thyroid-associated ophthalmopathy : a clinical study of 381 cases

  29. 细胞间黏附分子-1在甲状腺相关眼病泪腺组织中的表达及意义

    Expression of intercellular adhesion molecule-1 in lacrimal glands derived from thyroid associated ophthalmopathy

  30. 重视我国甲状腺相关眼病的基础与临床研究

    Emphasizing the fundamental and clinical research on thyroid-associated ophthalmopathy